Article Details

Regenxbio eyes 2026 filing for Duchenne muscular dystrophy gene therapy

Retrieved on: 2024-11-19 17:37:27

Tags for this article:

Click the tags to see associated articles and topics

Regenxbio eyes 2026 filing for Duchenne muscular dystrophy gene therapy. View article details on hiswai:

Excerpt

... cell and gene therapy development. DMD is a rare, progressive genetic disorder characterised by the degeneration and weakness of muscles. It ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up